November 21, 2022
UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.
October 30, 2014
…Diego Publications With first clinical trials, UC San Diego pushes stem cell therapies into a new era of real-world application In 2004, the therapeutic potential of stem cells persuaded more than 7 million Californians to approve Proposition 71, which allocated a whopping $3 billion for research and development of stem…
January 28, 2021
Researchers Expand Clinical Trials Investigating Convalescent Plasma Therapy for COVID-19 It’s hoped the long-used approach, which would use antibody-rich infusions, can either reduce disease symptoms or prevent infections after exposure to SARS-CoV-2 Parallel to COVID-19 vaccination efforts, physicians and researchers at UC San Diego Health, with collaborators across the country,…
October 4, 2016
…well as offering innovative clinical trials and the latest treatments with a personalized medicine approach. This expertise led to the selection of Moores Cancer Center as one of 12 clinical trial sites for the Pancreatic Cancer Action Network’s newly created Precision Promise, the first large-scale precision medicine trial network designed…
April 15, 2021
Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
May 15, 2012
Researchers at the Comprehensive Alzheimer’s Program at the University of California, San Diego School of Medicine have announced two new clinical trials for patients with either mild to moderate Alzheimer’s disease (AD) and one trial for Mild Cognitive Impairment.
June 1, 2018
Researchers at University of California San Diego School of Medicine report that a first-in-human phase I clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement in three of four subjects, with no serious adverse effects.
August 11, 2014
Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries. This Phase I clinical trial is recruiting eight patients for the 5-year study.
October 17, 2019
…newly established Precision Immunotherapy Clinic. Photo by Yadira Galindo/UC San Diego Health New Precision Immunotherapy Clinic Matches Patients to Latest Cancer Therapies Using a personalized approach, Moores Cancer Center at UC San Diego Health employs genetic profiling to treat patients who have not responded to, or relapsed from, standard treatments…
July 23, 2020
…for COVID-19; Neither are Clinical Trials Before the COVID-19 pandemic, physician-scientists Drs. Ezra Cohen, Catriona Jamieson, Dan Kaufman and Stephen Schoenberger discussed one of 195 cancer therapeutic clinical trials available at UC San Diego Health. These life-saving studies continue to be offered. With additional safety measures in place, clinical trials…
